Article Versions Notes

Montalesi E, Cracco P, Acconcia F, Fiocchetti M, Iucci G, Battocchio C, Orlandini E, Ciccone L, Nencetti S, Muzzi M, et al. Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway. International Journal of Molecular Sciences. 2023; 24(3):2148. https://doi.org/10.3390/ijms24032148

Montalesi, Emiliano, Patrizio Cracco, Filippo Acconcia, Marco Fiocchetti, Giovanna Iucci, Chiara Battocchio, Elisabetta Orlandini, Lidia Ciccone, Susanna Nencetti, Maurizio Muzzi, and et al. 2023. "Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway" International Journal of Molecular Sciences 24, no. 3: 2148. https://doi.org/10.3390/ijms24032148

Montalesi, E., Cracco, P., Acconcia, F., Fiocchetti, M., Iucci, G., Battocchio, C., Orlandini, E., Ciccone, L., Nencetti, S., Muzzi, M., Moreno, S., Venditti, I., & Marino, M. (2023). Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway. International Journal of Molecular Sciences, 24(3), 2148. https://doi.org/10.3390/ijms24032148